Down 97% From Record Highs, Is Sundial Stock a Buy Right Now?

Despite the 97% decline in Sundial stock from its record high, it remains a risky bet for long-term investors due to poor fundamentals.

| More on:
edit Jars of marijuana

Image source: Getty Images

Canadian cannabis company Sundial Growers (NASDAQ:SNDL) has been among the worst performers on the bourses since the stock went public in August 2019. Soon after its initial public offer, SNDL stock was priced at a high of US$11.5 and is now trading 97% below that, at US$0.56.

Let’s see what impacted Sundial stock in the past and if it is a good contrarian buy right now.

Sundial has massively diluted shareholder wealth

A key reason for the underperformance of Sundial can be attributed to shareholder dilution. In the five-month period between September 2020 and February 2021, the company issued 1.15 billion shares to offset its cash burn and lower its debt balance.

Further, last September, Sundial disclosed it will reduce its product portfolio and liquidate low-margin items to improve the bottom line. Sundial’s revenue was impacted by COVID-19 as its sales in 2020 stood at $60.9 million, compared to $75.8 million in 2019. Due to its strategic decision to exit certain markets, Sundial’s revenue in the last 12 months stood at $47.26 million.

In Q3 of 2021, Sundial reported sales of $14.4 million, an increase of 57% on a sequential basis. The growth in revenue was due to higher retail sales and the acquisition of Inner Spirit Holdings. However, its cultivation and production revenue stood at $8.2 million in Q3 compared to $9.2 million in Q2 and $9.9 million in Q1.

Sundial has burnt $173 million from its operating activities in the last four quarters. In Q3, its cash burn was $56 million, compared to $20 million in the year-ago period. As the company continues to focus on its retail cannabis business as well as the acquisition of Alcanna, its cash burn number might increase in the near term.

Sundial ended Q3 of 2021 with $571 in cash, providing it with enough liquidity right now. However, the balance could erode swiftly if Sundial goes on an acquisition spree, resulting in further shareholder dilution.

What next for SNDL stock?

In Q4 of 2021, Wall Street expects Sundial to report sales of $13.25 million, an increase of 15.4% year over year. However, it’s also expected to end 2021 with a loss per share of $0.07 which translates to net losses of $168 million.

Now, Sundial’s revenue might increase to $625.4 million in 2022 due to the Alcanna acquisition, which is one of the largest liquor retailers in Canada. Further, Alcanna’s subsidiary, Nova Cannabis, owns and operates 78 retail outlets across several provinces.

SNDL stock is valued at a forward price to sales multiple of less than three, which is quite reasonable given its growth forecasts. Despite falling sales, Sundial’s focus on selling high-margin products allowed the company to report an adjusted EBITDA of $10.5 million in Q3 of 2021. Analysts expect SNDL to break even on an adjusted basis by the end of 2022.

The Foolish takeaway

Sundial remains a high-risk bet considering the possibility of further shareholder dilution and less than impressive revenue growth. I believe there are far better pot stocks you can buy right now, given the risk-reward profile of Sundial.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »